secwatch.observer — SEC 8-K summary
======================================

Issuer:     Owlet, Inc. (OWLT)
CIK:        0001816708
Form:       8-K
Filed at:   2023-11-09T23:59:59+00:00
Accession:  0001628280-23-038331
Event type: regulatory
Sentiment:  positive
Materiality: 0.80
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Owlet receives FDA de novo clearance for Dream Sock as first OTC infant pulse oximeter
--------------------------------------------------------------------------------

- FDA-cleared Dream Sock monitors pulse rate and oxygen saturation for healthy infants 1-18 months, 6-30 lbs.
- Device provides Health Notifications with lights and alarms when readings fall outside preset ranges.
- Medical-grade features to roll out to existing and new Dream Sock users by end of 2023 (U.S. only).
- Follows prior FDA clearance of prescription BabySat system; Dream Sock now available without prescription.
- CEO calls it a 'significant breakthrough' in at-home infant care and commitment to innovation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1816708/000162828023038331/0001628280-23-038331-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1816708/000162828023038331/owlt-20231109.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-038331

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer